Here’s How Novavax’s Vaccine Stacks Up Against Moderna’s and Pfizer’s

Novavax (NASDAQ: NVAX) shares climbed 2,700% last year as investors bet on the biotech company’s investigational coronavirus vaccine. But the share price’s story doesn’t end there. Last week, the stock soared nearly 65% in just one trading session. What prompted such a jump? NovaRead MoreMarketsMarkets Feed